-
4141
The analgesic effectiveness of auriculotherapy for acute postoperative pain: A systematic review and meta-analysis
Published 2025-03-01“…Methods: We searched the MEDLINE, Web of Science, Embase, Cochrane Library, CINAHL Complete, and ClinicalTrials.gov from inception to January 23, 2024 for all randomized controlled trials (RCTs) of auriculotherapy in the treatment of APP. …”
Get full text
Article -
4142
Quality of life, pain, depression, fatigue and sleep in patients with remission or mild fibromyalgia: a comparison with remission or low disease activity rheumatoid arthritis and h...
Published 2025-01-01“…Trial registration ClinicalTrials.gov Identifier: NCT02449395, registered on May 20, 2015.…”
Get full text
Article -
4143
A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patientsResearch in context
Published 2025-02-01“…This trial was registered at Japan Registry for Clinical Trials (jRCT2031210453). Findings: Fifty-four patients were randomised (teprotumumab, 27; placebo, 27) between February and November 2022. …”
Get full text
Article -
4144
Safety and efficacy of edoxaban monotherapy after bioabsorbable polymer everolimus-eluting stent implantation in a human-like coronary atherosclerotic porcine model
Published 2025-03-01“…These results provide important preclinical evidence supporting the potential of DOAC monotherapy as an antithrombotic strategy after DES implantation and warrant further investigation in clinical trials.…”
Get full text
Article -
4145
Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms
Published 2025-02-01“…The objective of this study was to evaluate the psychometric performance of the QOL-E in patients with LR-MDS.MethodsData from four clinical trials in MDS (MEDALIST, DARB-MDS, EQoL-MDS, and RevMDS trials) were used to assess construct validity, reliability, and responsiveness. …”
Get full text
Article -
4146
A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databases
Published 2025-01-01“…Abstract Objective Paliperidone palmitate is a second-generation antipsychotic that has undergone extensive investigation in clinical trials. However, real-world studies assessing its safety in large populations are lacking. …”
Get full text
Article -
4147
Evaluating the feasibility, sensitivity, and specificity of next-generation molecular methods for pleural infection diagnosis
Published 2025-02-01“…These data will help to inform the design of larger prospective clinical trials and identify potential obstacles to be overcome before next-generation sequencing technologies can be integrated into routine clinical practice.…”
Get full text
Article -
4148
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis
Published 2025-01-01“…Methods The PubMed, SCOPUS, Web of Science Core Collection, Cochrane Library, and ClinicalTrials.gov. databases were searched from January 2000 and December 2023, articles were primarily evaluated regarding their titles and abstracts, then full-text screening was assessed against the inclusion and exclusion criteria by utilizing Rayyan software. …”
Get full text
Article -
4149
Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study
Published 2025-01-01“…Objectives DARWIN 3 (ClinicalTrials.gov: NCT02065700) assessed the safety and efficacy of filgotinib in a long-term extension (LTE) of two phase II randomised controlled rheumatoid arthritis (RA) trials.Methods Eligible patients completing the 24-week DARWIN 1 (filgotinib plus methotrexate) and DARWIN 2 (filgotinib monotherapy) trials could enrol. …”
Get full text
Article -
4150
Multimodal Deep Learning for Differentiating Bacterial and Fungal Keratitis Using Prospective Representative Data
Published 2025-03-01“…We also compared the performance of the MADURAI-trained computer vision model against a model with identical architecture but trained on a preexisting dataset collated from multiple prior bacterial and fungal keratitis randomized clinical trials (RCTs) (the RCT-trained computer vision model). …”
Get full text
Article -
4151
The in vivo metabolic pathway of Deg-AZM and in vitro investigations into the contribution of drug metabolizing enzymes and drug transporters in the drug interactions of Deg-AZM, a...
Published 2025-01-01“…IntroductionDeglycosylated azithromycin (Deg-AZM), a new transgelin agonist with positive therapeutic effects on slow transit constipation, has been approved for clinical trials in 2024. This work investigated the drug metabolism and transport of Deg-AZM to provide research data for further development of Deg-AZM.MethodsA combination of UPLC-QTOF-MS was used to obtain metabolite spectra of Deg-AZM in plasma, urine, feces and bile. …”
Get full text
Article -
4152
Exercise medicine as adjunct therapy during RADIation for CAncer of the prostaTE to improve treatment efficacy – protocol for the ERADICATE study: a phase II randomised controlled...
Published 2025-01-01“…Trial registration The study was registered on the Australian New Zealand Clinical Trials Registry (ACTRN12624000786594) on 26/06/2024.…”
Get full text
Article -
4153
Investigating the impact of microbiome-changing interventions on food decision-making: MIFOOD study protocol
Published 2025-01-01“…Trial registration ClinicalTrials.gov NCT05353504. Retrospectively registered on 29 April 2022.…”
Get full text
Article -
4154
Etoposide targets 2A protease to inhibit enterovirus 71 replication
Published 2025-01-01“…The findings indicate that Etoposide serves as a promising inhibitor of the EV71 2Apro, demonstrating strong antiviral properties and positioning itself as a formidable candidate for clinical trials against EV71.IMPORTANCEWe first used a drug screening approach focused on monomeric compounds and their derivatives from traditional Chinese medicine to identify an EV71 2Apro inhibitor—Etoposide. …”
Get full text
Article -
4155
Movement therapy in advanced heart failure assisted by a lightweight wearable robot: a feasibility pilot study
Published 2022-06-01“…This trial was registered at ClinicalTrials.gov: NCT04839133.…”
Get full text
Article -
4156
Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma
Published 2021-04-01“…Therefore, sGPC3 acted as dominant negative regulators when competed with cell surface GPC3 to bind anti-GPC3 CAR-T cells, leading to an inhibitory effect on CAR-T cells in HCC.Conclusions We provide a proof-of-concept study demonstrating that GPC3 shedding might cause worse response to CAR-T cell treatment by competing with cell surface GPC3 for CAR-T cell binding, which revealed a new mechanism of tumor immune escape in HCC, providing a novel biomarker for patient enrolment in future clinical trials and/or treatments with GPC3-targeted CAR-T cells.…”
Get full text
Article -
4157
Efficacy and Safety of Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled by Amlodipine: A Phase III, Multicenter, Double‐Blind, Parallel‐Group, R...
Published 2025-01-01“…Trial Registration: ClinicalTrials.gov identifier: NCT06465264…”
Get full text
Article -
4158
Efficacy of non-surgical mechanical debridement with and without adjunct antimicrobial photodynamic therapy in the treatment of peri-implantitis among patients undergoing chemother...
Published 2025-04-01“…Hence further long-term follow-up clinical trials involving multiple sessions of aPDT after MD are needed.…”
Get full text
Article -
4159
Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility study
Published 2020-09-01“…Peer reviewed publications and conference presentations will report the findings of this novel study.Trial registration number Australian New Zealand Clinical Trials Registry (ACTRN12619001649101).…”
Get full text
Article -
4160
Evaluation of Biologics ACE2/Ang(1–7) Encapsulated in Plant Cells for FDA Approval: Safety and Toxicology Studies
Published 2024-12-01“…Vital biomarkers and organs were not adversely affected despite the 10-fold higher absorption in the tissues, demonstrating the safety for the first in-human clinical trials of ACE2/Ang(1–7). The NOAEL observed in the rats was 2.5–7.5-fold higher than that of the anticipated efficacious therapeutic dose in humans for the treatment of cardiopulmonary disorders, and it was 314-fold higher than the NOAEL for topical delivery via chewing gum. …”
Get full text
Article